Cytological and histological characteristics of normal and freemartin gonads have been studied in 45-, 60-, and 90-day bovine fetuses during gonadotropin-induced multiple pregnancy. In both sexes of 45-day fetuses the second proliferation of germinal epithelium was not developed whereas the primary tunica albuginea was well developed. Fetal testes showed higher cell activity than fetal ovaries. Mitotic activity seemed slower in 60-day freemartin gonads than in normal fetal ovaries. The chromosomal stages prophase, metaphase, anaphase and telophase corresponding to oogonia were less numerous than in normal fetal ovaries. The cytological appearance of freemartin gonads in 60-day fetuses was unaffected by the ratio of male: female fetuses. The freemartin gonad was characterized by an irregular distribution of cortex and primary tunica albuginea. In the ovaries of 90-day fetuses the last chromosomal stage observed in the oocytes was the pachytene stage. The first establishment of primordial follicles was observed.

This content is only available via PDF.
© 1964 S. Karger AG, Basel
1964
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.